The ShiftShapers Podcast
Change either paralyzes or energizes - the choice is yours. Hear from businesses and entrepreneurs who have become energized and who have profited by shaping the shifts in their markets and practices. Become a SHIFTSHAPERS INSIDER and get our latest download, advance notice of all podcasts, podcast summaries, and special INSIDER-ONLY content. INSIDER SIGN UP
The ShiftShapers Podcast
Ep #208: Fee For Service Is The Crack Cocaine Of Healthcare – with Brian Klepper
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Brian Klepper, Principal at HC Performance Inc. and Worksite Health Advisors believes that the value being delivered in today’s health care system is a “train wreck” and that many are complicit – and know that they are complicit. He explains why he believes that Fee For Service is the crack cocaine of healthcare. The good news is that Brian sees a new model emerging that focuses on delivering value across the entire health care delivery chain.
What You’ll Learn From this Episode:
- What the current system looks like and why it’s a problem for all constituencies.
- How value-based care is defined.
- What the key metrics are.
- Whether or not employers are beginning to understand this change.
- Is there a new, emerging class of high-performance health providers?
Is fever service medicine the crack cocaine of healthcare? And how can we move from the devastation it's caused to a world of value-based care? We'll find out on this episode of Shift Shapers.
SPEAKER_01Either paralyzes or energizes. The choice is yours. You're listening to the Shift Shapers Podcast. You're about to learn firsthand from businesses and entrepreneurs who have successfully shaped the shifts in their industry. Get ready to become the change that you want to study. Here's your host and chief transformation strategist, David Saltman.
DavidThis episode of the Shift Shapers Podcast is brought to you by Captivated Health, a captive insurance arrangement that helps small and mid-market companies escape the fully insured marketplace and delivers stability, control, and savings without watering down employees' benefits or increasing their premium share. If you have clients in the educational institution or the engineering vertical, go to our website at captivatedhealth.com or click on the company logo on the Shift Shapers website. On this episode of Shift Shapers, we're speaking with Brian Klepper. Brian is principal at Healthcare Performance Inc. and Worksite Health Advisors. And he believes there's an emerging model that focuses on value. Now we've talked a bit about value in different contexts in earlier episodes. This is something where Brian has done a deep dive. He may be one of the three or four most foremost experts on this subject. And so we're pleased that we were able to capture a little bit of his time to chat with us. And with that, welcome, Brian. Thanks so much. So in our pre-interview, I'm always interested in words. In our pre-interview, we talked a little bit about how you believe we're moving towards value, but that where we are today is a train wreck. Those are strong words. I'm not sure that they're unwarranted, but they're certainly strong words. Explain why you believe that and what you see as the train wreck that is today's model.
SPEAKER_02Well, you know, guys like like me, like us, have talked about the healthcare cost crisis for 25 years. But when you switch your position and you start looking into individual high-value niches, musculoskeletal care, which is a quarter of all the money we spend, cardiometabolic, which is which is probably a little less than that, drugs, which is 15 to 20 percent, imaging, which is 10 to 15 percent. What you see is that in every area of healthcare, every area that you look at at all, the utilization is excessive, the pricing is egregious, and we really have evolved to a model where we do things on behalf of the people in the healthcare industry rather than for patients and for purchasers. There's really very little value. An example of this, David, would be in spinal care, where half of the surgeries that are done are completely inappropriate and unnecessary. They're not warranted. In orthopedic care, which does not have a reliable diagnostic methodology, so double the surgeries get done that should be done. In cancer, where 96% of advanced patients are going to die, and two-thirds of the drugs that have been approved by the FDA in the last decade have no evidence that they actually work. They've been approved on what are called surrogate metrics like progression-free survival. We have an entire healthcare industry that is built on the set of false assumptions that we're actually doing stuff that that works when in fact we're paying double what we should be paying, and could legitimately pay half of what we are we're currently paying for much better health outcomes and and much better, much better costs.
DavidSo how did we get there? Is it just a money thing?
SPEAKER_02It is not just a money thing, but it's largely a money thing. It's a lack of professionalism among clinicians, and it's the utter corporatization of health care as well. I mean, everybody in the industry is complicit in this. And if you dig down deep, everybody knows that they're complicit. So health plans, for example, will swear up and down that they don't have any influence over the care that's delivered, but they make decisions about which providers are going to be on the network and what they're going to pay for and what they're not going to pay for. They're of course complicit. They're they're driving this problem. And the real the real issue ends up being, like you say, money because at the end of the day, everybody is going to say that they believe in greater value. It's just that nobody wants to make lower per patient revenues.
DavidIs the employer-based system the reason in large measure why there hasn't been a patient or a consumer revolt over this?
SPEAKER_02That's a good question. I I don't quite know the answer to that. The advantage to having an employer-based system is that you have is that employers represent aggregations of patients and large purchasing power. The problem with a consumer-based system is that consumers are easily misled, they're easily led and misled, and and they don't have a center of power. So what has ended up happening in the US is that we have a Congress that is that has its arms open wide to money purchased influence to lobbying, which is essentially just bribery. And so the whole policy framework has evolved to support the egregious practices of the industry. I mean, if if I was if I were going to give you a taxonomy of the big problems in healthcare, at the top of the pyramid is is lobbying. Lobbying is the cancer on the democracy. And and in healthcare, it controls virtually everything. And an example of this is that in 2009, the year that the ACA was was formulated, Congress accepted $1.2 billion in campaign contributions in exchange for influence by the industry over the shape of the law. That's why the law looks like it does. It wasn't written specifically by the Democrats. It was written by the industry with the complicity of the Democrats who received a lot of that money. And as an example of the impact of that, you can look at the stock prices of healthcare health plans, Aetna, Insignia, United, Anthem, Humana. And their stock prices have grown between 600 and 800% just in the eight years since. So I mean it it's a pr it's a profound problem. The three other major problems are a lack of transparency of cost and quality and safety data, it's fee-for-service reimbursement, which is the crack cocaine of health care, and it's the subjugation of primary care, which has happened over a long period of time. The goal being to get around the primary care function and get patients right to the place where it's much more lucrative. I know that this sounds very cynical, but when you when you look closely at the system and you and you've been watching it as long as I have, these these conclusions are are are inescapable.
DavidSo let's dive in a little bit deeper. What is, we talk a lot about value-based healthcare, a lot of a lot of practitioners talk about it. What's the best definition of that if we want a level set?
SPEAKER_02Aaron Powell Of value. Yeah. Yeah, I think I think simply value is cost per unit quality. And we too often look at quality without cost information or simply cost information. We make purchasing decisions on that. And because of that, we have evolved to a place in American healthcare where we don't pay much attention at all to quality. And as a result, we have wild variations in quality for the same thing within the same market, even. We don't hold people to standards. Most provider organizations that are delivering care have no meaningful quality management structure in place. So you sort of get whatever you get. And if people do things to patients and they don't have to look at what the results actually are, then they just assume that it went okay. You know, as opposed to setting up a set of quality performance indicators, quality metrics. And every time you do an intervention, you look at those performance metrics and say, did I get the result that was desired? Because if I didn't, I I must need to rethink my model and course correct my treatment pathway. We don't do that in American healthcare. And we sorely need to. That's that's one of the core problems.
DavidAnd now a word from our sponsor. Captivated Health is a single source solution for your clients and prospects in the education and engineering verticals. The founders of Captivated Health have 35 years experience working with healthcare and benefit clients. And over that time, they've developed a keen understanding of the unique problems mid-market clients experience. Frustrated by a lack of control, the unpredictability of ever-increasing health care costs, and the pressures and regulations of the Affordable Care Act, these groups have been adrift in the fully insured commercial marketplace. Until now. Captivated Health has built a program that solves those problems and does so with virtually no disruption to employees while saving clients millions of dollars. We wanted you to be among the first to know that Captivated Health is building a national distribution partner network so you can bring this cutting-edge solution to your education and engineering clients that you advise. To learn more about Captivated Health's solution, go to our website at www.captivatedhealth.com or click on our logo on the Shift Shapers website. And yet for a long time there's been this perception among plans, let's use that generically and broadly, that higher cost is equivalent to higher quality. And that just is not the case, is it?
SPEAKER_02Absolutely not true at all. And as as a lot of the companies that I work with are able to show, the best care is based on evidence. And it's very often most streamlined and much less costly. As a matter of fact, I would say that we could, we will show in the next 10 to 15 years that compared with today's pricing and today's quality, we'll be able to deliver far better health outcomes at dramatically lower cost on the order of half or less of what we're currently paying now.
DavidThat's astonishing. Are we seeing, and I know that they're doing remarkable stuff, are we seeing any US-based evidence that we're starting to move towards value-based rather than this crazy pricing system that we've got?
SPEAKER_02Aaron Powell The incentives are so strongly aligned against that. So, for example, I can I can introduce you to a number of people who have been running accountable care organizations for hospitals where they've come to loggerheads with their senior teams that that hired them, who don't want them to do the work that they were hired to do because it lowers per patient revenues. You know, you can say all day long, you know, I I really, really believe in value, but you know, just so long as it doesn't affect my revenues. Well, the fact is that half or more of everything we spend on health care is unnecessary and inappropriate. You know, the the examples I gave in orthopedics are not exaggerated. I can show you very clearly in data that half of the stuff that we do in orthopedics provides no benefit at all and often oftentimes is not warranted in the first place. The same goes in all these other areas of medicine. So if you were to restructure the system and only pay for things that did provide value, the cost structure of the system would be dramatically changed and it would cause, it would wreak havoc on the on the industry, because the industry is has come to depend on the revenues that are illegitimate.
DavidHow do you get to that point? I mean, it just seems like almost an insurmountable mountain.
SPEAKER_02What you say is true, but but there's only one way to do it that I can that I can think of. Because and and the trick here is, as we said before, Congress is owned by the industry. So it's it's irrational at the end of the day to try to fix healthcare through policy. I'm not a supporter of any of that because at the end of the day, policy is shaped by the guy who has the biggest checkbook, and Congress is all in with that idea. And we haven't been able to do anything to fix that problem, which by the way erodes democracy. There's no question about that. But the fact remains, Congress accepts money from special interests and they spin legislation to their favor in exchange for that money, and that's just the way it is. So if you want to if you want to fix health care, the only place to do it is in the market. And the way to do that is to basically offer a better deal, make them an offer they can't refuse. And it turns out that there are organizations in healthcare that are emerging and that that are in high value niches. I'm not talking about things like wellness. I'm talking about places where the money really is: musculoskeletal care, cardiometabolic care, cancer care, imaging, drug management, where the money really is. And these companies, I refer to them generically as high performance companies, but they are they're interesting sociologically. They're led by people who are who tend to be passionate and mission-driven, they tend to be data and evidence driven, and they have high subject matter expertise in some niche. And they will, they have rethought, deconstructed some problem in healthcare that we're all reasonably familiar with, and they've come up with a completely different answer than everybody else. And then they've refined it. And they're usually they're usually able to demonstrate that they can get not just better results, they get wildly better results at a fraction of the cost of conventional care. The health plans, as it turns out, are not much interested in these companies because if they make health care cost less, the health plans' earnings will be less, and that means their stock price and their market capitalizations will be less too. So the so there is a perverse incentive in the organizational structure, the legal structure of organizations to make healthcare continue to cost more. Let me give you some examples of what I'm talking about with the high performance companies. So it turns out that there is a company in Florida that specializes in musculoskeletal management. And they now have a number of very large clients: Michelin, the U.S. Army, General Dynamics, companies like that, serious clients. And they've been in place for a number of years, and so they have several hundred thousand patient encounters under their belt. They're built on not orthopedics, but on a subdiscipline of physical therapy that's highly credible, comes out of New Zealand called the McKinsey method. It's also called mechanical diagnosis and therapy, and it has a very accurate diagnostic methodology that orthopedics does not use. And the data show, after hundreds of thousands of patients, that this organization is able to intervene on about 80% of musculoskeletal cases, and that it gets hugely better health outcomes, pain reduction, activities of daily living, range of motion, and it does it in half the recovery time and at half the cost of conventional orthopedics. It reduces surgeries by two-thirds compared to conventional orthopedics. It reduces imaging by half and injections by a third. To put this in perspective, musculoskeletal care is a quarter of all the money we spend in group health care, and it's 60% of all the money we spend in occupational health care. It's an enormous piece of the healthcare puzzle. And so if you're a company like a Michelin and you do this one thing, your total healthcare spend is going to drop somewhere between five and 13, 14%, and your health outcomes of your patients are going to be way better than they would be ordinarily. I mean, it's profound, it's dramatic, and it's simply a better approach. There's a similar, a similar company that does a similar methodology, but in cardiometabolic care, patients who have diabetes and heart conditions and hypertension and things like that. In a recent study that came out in the American Journal of Managed Care, the people behind this company did a project for Blue Cross of Louisiana, where they trained 600 primary care physicians around the state in how to better take care of these patients who had these kinds of conditions. And in the first year, with only part of the physicians really buying in and actively supporting this approach, it dropped total spend on that condition by about more than $300 per patient. And the health outcomes were dramatically better. They almost doubled their achievement of performance targets for hypertension and diabetes compared to regular care. So we have found this this sort of thing in cancer, in in drug management. You ought to be able to buy all the drugs that we're buying now, but for about 35% less than we're currently spending. The same thing in imaging. We ought to be able to spend half of what we're currently spending on imaging, and so on. And when you put all these things together, and if you were to put them all under one umbrella, the math shows that you should easily be able to provide better health outcomes for about half the money. But if you're looking at it from a business perspective, think of it this way: you can get better health outcomes for, let's say, 25% less than you're currently spending, but with 10% for the company that put it together for their margin, and another 15% for Wiggle. In other words, you we don't have to be exorbitant about it or make wild claims, but the math absolutely says this, and there will be people who go down this path.
DavidIn the two or three minutes that we have left, how do you see this getting out into the mid and mid-large markets?
SPEAKER_02It's happening now. I have a number of mid-sized and large clients who are all headed in this direction. They see the logic of it and they're absolutely thrilled about it. I'm talking to audiences all over the country, audiences of employers and unions all over the country, and they they see that there's no other approach that works. And they're willing to look at the data and consider it, and then they're and then they're they're proceeding. So there is a sh, I mean, to my mind, after 25 years of working in this area, I'm the most optimistic that I've ever been about this problem because of the emergence of these kinds of companies in the marketplace.
DavidThat's a great place to end our interview for today. Brian Klepper, principal at Healthcare Performance Inc. and Worksite Health Advisors. Brian, thanks for a fascinating discussion.
SPEAKER_02Thank you, David. I really appreciate the time. I enjoyed it.
DavidThe Shift Shapers Podcast is a production of the Saltzman Group. We work with entrepreneurs, executives, and companies just like you to help shape the shifts in your business. To schedule a 20-minute call to learn more, visit our website at thesaltzmangroup.com or call me directly at 803-386-8005. I'd love to hear from you. And while you're on our site, you can also click the podcast tab for the entire catalog of chip shapers episodes and to access some really great special offers. Give me a call at 803 386 8005 and learn how to put the secrets of the chip shapers to work in your business.